ICU Medical, Inc.

ICUI • Medical - Instruments & Supplies

$167.58

▲ +1.29 (+0.78%)

Precio actual

ResultadosÚltimo reporte: 30 jun 2026

PERFIL EQUILIBRADONeutralConfianza: 70%

Perfil cuantitativo — no constituye una recomendación de inversión.

Perfil cuantitativo — no constituye una recomendación de inversión.Metodología

Tesis del análisis: Perfil mixto. La empresa no es necesariamente mala, pero la valoración, el crecimiento o el balance todavía no justifican una señal más fuerte.

Capitalización

$4.20B

Crecimiento

14.5%

Flujo de caja

4/5

Tendencia

Mostly stable

Evidencia

Crecimiento positivo de ingresos · 9.9%Flujo de caja libre positivo · 3.73Flujo de caja libre consistente · 4/5Nivel de deuda manejable · 0.66Liquidez saludable · 2.36

Datos financieros hasta: 30 jun 2026, 12:00 a.m. UTCÚltima actualización de earnings: 30 jun 2026, 12:00 a.m. UTCÚltima actualización del perfil: 7 ago 2026, 12:51 p.m. UTC

Resumen de la compañía

Valoración, calidad, fortaleza financiera, momentum y datos de analistas.

Price$167.58

Change0.78%

Shares Out25.04M

Market Cap$4.20B

Enterprise Value$5.13B

52W Range107.00 - 176.27

Beta0.76

P/E139.48

P/S1.94

P/B1.95

P/FCF23.49

EV/Sales2.38

Price$167.58

Change0.78%

Shares Out25.04M

Market Cap$4.20B

Enterprise Value$5.13B

52W Range107.00 - 176.27

Beta0.76

P/E139.48

P/S1.94

P/B1.95

P/FCF23.49

EV/Sales2.38

EV/EBITDA14.68

EV/FCF28.71

Earnings Yield0.72%

FCF Yield4.26%

Dividend Yield0.00%

Gross Margin36.76%

Oper. Margin4.80%

Profit Margin0.03%

Debt/Eq0.66

Current Ratio2.36

Quick Ratio1.13

Revenue 5Y14.52%

FCF 5Y7.45%

Target$186.40

Target Upside11.23%

Target Median$187.00

Target Range163.00 - 200.00

Volume346.38K

Avg Volume295.14K

EPS Surprise0.19

ADN de inversión

Qué tan fuerte luce esta compañía para inversionistas de largo plazo

de 100

Calidad del negocio

Márgenes, ventaja competitiva, retornos

35/100

Fortaleza financiera

Deuda, caja, estabilidad

68/100

Potencial de crecimiento

Ingresos y expansión

57/100

Atractivo del precio

Barata o cara hoy

61/100

Por qué este puntaje▼

Crecimiento positivo de ingresos · 9.9%Flujo de caja libre positivo · 3.73Flujo de caja libre consistente · 4/5Nivel de deuda manejable · 0.66Liquidez saludable · 2.36Múltiplo de ganancias caro · 4802.44

Analyst view

Analyst sentiment and price target

ICUI

Analyst sentiment

Based on 12 analyst votes · 2026-09-05

96/100

Bullish

Hold

Bearish

Precio objetivo

2026-08-07

Bajo

$163.00

Promedio

$182.00

Mediana

$182.00

Alto

$200.00

Resumen de la compañía

IPO: 3/31/1992

Industria: Medical - Instruments & Supplies

P/B i: 1.95

Deuda / Patrimonio i: 0.66

Margen operativo: 4.80%

Margen neto: 0.03%

ROE i: -

ROIC: -

Salud financiera

Puntaje14 / 20

Deuda / Patrimonio: 0.66

Ratio corriente: 2.36

Ratio rápido: 1.13

Estado: Good

Transacciones internas

Actividad reciente de ejecutivos e insiders

Woolson Daniel

Transacción: 05/22/2026

VENTA

Cambio

-2,123

Precio

$132.21

Presentación

05/22/2026

Tipo

VENTA

Sanzone Virginia Ruth

Transacción: 05/14/2026

VENTA

Cambio

-2,447

Precio

$124.08

Presentación

05/15/2026

Tipo

VENTA

Greenberg David C.

Transacción: 05/13/2026

VENTA

Cambio

-1,254

Precio

Not reported

Presentación

05/13/2026

Tipo

VENTA

Insider	Tipo	Cambio	Precio	Transacción	Presentación
Woolson Daniel	VENTA	-2,123	$132.21	05/22/2026	05/22/2026
Sanzone Virginia Ruth	VENTA	-2,447	$124.08	05/14/2026	05/15/2026
Greenberg David C.	VENTA	-1,254	Not reported	05/13/2026	05/13/2026
Hoffmeister David F	VENTA	-1,254	Not reported	05/13/2026	05/13/2026
Abbey Donald	VENTA	-1,254	Not reported	05/13/2026	05/13/2026
FINNEY ELISHA W	VENTA	-1,254	Not reported	05/13/2026	05/13/2026
Hernandez Laurie	VENTA	-1,254	Not reported	05/13/2026	05/13/2026
KENNEDY KOLLEEN T	VENTA	-1,254	Not reported	05/13/2026	05/13/2026
Greenberg David C.	VENTA	-2,424	$101.06	05/12/2026	05/13/2026
Greenberg David C.	VENTA	-2,424	$122.91	05/12/2026	05/13/2026
Abbey Donald	VENTA	-704	Not reported	03/25/2026	03/26/2026
Bonnell Brian Michael	VENTA	-11,400	Not reported	03/15/2026	03/16/2026
Bonnell Brian Michael	VENTA	-3,248	Not reported	03/15/2026	03/16/2026
Jain Vivek	VENTA	-17,100	Not reported	03/15/2026	03/16/2026
Jain Vivek	VENTA	-4,872	Not reported	03/15/2026	03/16/2026
Sanzone Virginia Ruth	VENTA	-5,700	Not reported	03/15/2026	03/16/2026
Sanzone Virginia Ruth	VENTA	-1,624	Not reported	03/15/2026	03/16/2026
Sousa Ben	VENTA	-1,300	Not reported	03/15/2026	03/16/2026
Woolson Daniel	VENTA	-2,924	Not reported	03/15/2026	03/16/2026
Woolson Daniel	VENTA	-1,295	$125.85	03/15/2026	03/16/2026

Sobre la compañía

ICU Medical, Inc.

ICU Medical, Inc., operating globally through its subsidiaries, is a medical technology firm that specializes in the development, manufacture, and sale of devices for both infusion therapy and critical care. Their extensive product line for infusion therapy encompasses: Needlefree Connectors: Such as the MicroClave, MicroClave Clear, and NanoClave brands. Catheter Maintenance & Disinfection: Including Neutron patency devices and SwabCap/SwabTip disinfecting caps. Hemodialysis Solutions: Like Tego connectors and ClearGuard HD antimicrobial caps. Hazardous Drug Handling: With closed system transfer devices (ChemoClave, ChemoLock) and the Diana compounding system for safe preparation. They also provide a comprehensive range of intravenous (IV) solutions, diluents, and irrigation fluids, available in diverse packaging options like flexible containers and pour bottles. These include common formulations such as sodium chloride, dextrose, balanced electrolytes, lactated ringer's, mannitol, and sterile water, alongside specialized irrigation solutions like acetic acid and glycine. In medication management, ICU Medical offers sophisticated infusion pumps, including the Plum 360 and LifeCare PCA brands. Its advanced ICU Medical MedNet software enhances medication safety by integrating smart pumps with hospital electronic health records (EHRs), asset tracking, and alarm notification platforms. Accompanying professional services are also provided. For critical care environments, their portfolio features: Hemodynamic Monitoring: Systems like Cogent 2-in-1 and CardioFlo. Cardiac Output & Oximetry: TDQ, OptiQ, and TriOx catheters. Blood Pressure Transducers: Such as Transpac. Blood Sampling Systems: Including the SafeSet closed blood sampling and conservation systems. The company distributes its products to a wide spectrum of healthcare providers, including acute care hospitals, wholesalers, ambulatory clinics, and various alternate site facilities such as outpatient clinics, home healthcare services, and long-term care centers. Established in 1984, ICU Medical maintains its headquarters in San Clemente, California.

Fuente - Link

Competidores

ARQT HAE HTFL IRON LIVN PBH PRGO TARS TVTX XRAY

Tamaño = capitalización · color = línea del gráfico

Rendimiento de peers · 1A

Top performers + empresa seleccionada

Ultimas Noticias

ICU Medical to Participate in Upcoming Investor Conferences

SAN CLEMENTE, Calif., Aug. 27, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced its participation in the following investor conferences: Wells Fargo 21st Annual Healthcare Conference on September 9-10, 2026 Company management will attend the Wells Fargo 21st Annual Healthcare Conference, held at the Encore Boston Harbor in Boston, MA, participating in one-on-one meetings on Wednesday, September 9 and Thursday, September 10, 2026.

GlobeNewsWire

BlackRock Inc. Takes $550.25 Million Position in ICU Medical, Inc. $ICUI

BlackRock Inc. acquired a new position in shares of ICU Medical, Inc. (NASDAQ: ICUI) during the quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 3,753,409 shares of the medical instruments supplier's stock, valued at approximately $550,250,000. BlackRock Inc. owned about 15.02% of ICU

Defense World

Emerald Investment Advisers LLC Acquires New Position in ICU Medical, Inc. $ICUI

Emerald Investment Advisers LLC acquired a new stake in ICU Medical, Inc. (NASDAQ: ICUI) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 25,314 shares of the medical instruments supplier's stock, valued at approximately $3,711,000. Emerald Investment Advisers LLC owned about 0.10%

Defense World

California State Teachers Retirement System Grows Position in ICU Medical, Inc. $ICUI

California State Teachers Retirement System grew its stake in shares of ICU Medical, Inc. (NASDAQ: ICUI) by 25.2% during the quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 27,512 shares of the medical instruments supplier's stock after purchasing an additional 5,536 shares during the period.

Defense World

ICU Medical Analysts Boost Their Forecasts Following Upbeat Q2 Earnings

ICU Medical Inc (NASDAQ:ICUI) on Thursday posted upbeat earnings for the second quarter.

Benzinga

Sorpresas de ganancias

Período	Estimado	Real	Sorpresa
2026-05-07	1.78	1.97	0.19
2026-02-19	1.68	1.91	0.23
2025-11-06	1.43	2.03	0.6
2025-08-07	1.44	2.1	0.66
2025-05-08	1.23	1.72	0.49
2025-02-27	1.48	2.11	0.63
2024-11-12	1.25	1.59	0.34
2024-08-07	0.98	1.56	0.58
2024-05-07	0.84	0.96	0.12
2024-02-27	1.18	1.57	0.39
2023-11-06	1.29	1.57	0.28
2023-08-07	1.55	1.88	0.33